Our Company4TECH Inc. is a privately held clinical-stage company that is incorporated in Delaware, USA, with operations in Galway, Ireland (4TECH Cardio Ltd). The company is dedicated to developing a minimally invasive transcatheter solution for the treatment of functional tricuspid regurgitation. In collaboration with key experts in the Structural Heart field and a combination profound experience, 4TECH is dedicating to improving patients’ quality of life through pioneering clinically advanced technology that offers an alternative solution for physicians and their patients suffering from tricuspid regurgitation.
Yossi is a engineer, inventor and entrepreneur with 30+ years of experience as entrepreneur in the medical device industry.
Hugo is a cardiac surgeon at OLVZ Aalst, Belgium, with a concentration in minimally invasive mitral and tricuspid valve repair
Francesco is the head of Cardiovascular Surgery and a full professor at the University Hospital Zurich, Switzerland. He is recognized as an expert for minimally invasive valve surgery and widely considered as a representative of a new generation of cardiovascular surgeons. He has a wealth of experience in transcatheter valve treatments.
Carine was the former CEO at 4TECH. Previously she served as director at Medtronic, Europe, and launched the first transcatheter aortic valve.
Our Board Members
Bill has been the Chairman of the Board of Directors of 4TECH since October 2016. He was a Senior Advisor for TPG Capital and Corporate Director of Immucor, Inc. Prior to Immucor, Bill served as Chairman and CEO of Medtronic from 2008 – 1011, which he joined in 2002 as Senior Vice President and President of Medtronic Vascular.
Lawrence has served on the Board of Directors of 4TECH since 2011 and served as Chairman from 2011 to 2015. He founded OXO Capital LLC and has been Chairman since 2007. Lawrence served as Chief Financial Officer of Boston Scientific Corporation since 1992. He was previously Senior Partner of Ernst & Young, where he specialized in serving multinational companies in the high technology and life sciences fields.
Eric has been on the Board of Directors of 4TECH since 2015. He has served as the Chief Executive Officer and President of Endosense SA until September 2011. He previously worked for Guidant from 1989 to 2004, holding various leadership positions on three continents.
Rudi has been on the Board of Directors of 4TECH Inc since 2015. He is a Founder and Managing Director of several clinical reference laboratories and has served as a director for various medical device companies.
Jan has served on the Board of Directors of 4TECH since 2015. He is the Founder, Chief Executive Officer, and Chief Investment Officer of Valiance Advisors LLP. Jan previously served as the Chief Executive Officer at La Fayette Investment Management from 2003 to 2007.
Ben has served on the Board of Directors of 4TECH since 2011. He is a Partner at Invus Opportunities, a New York-based private equity firm. Ben joined the firm in 2008 and has led a dozen medtech investments since 2010.